When signaling goes astray: understanding MAP2K1 mutations in neurodevelopmental disorders
Acta Crystallographica Section A Foundations and Advances · 25.08.2026 · 81 (a1) · e266-e266
DOI: 10.1107/s2053273325097359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Crystallographica Section A Foundations and Advances, erschienen am 25.08.2026. Verfasst von P. Havlickova und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Havlickova, P., Koutska, A., Smatanova, I. K., & Fenckova, M. (2026). When signaling goes astray: understanding MAP2K1 mutations in neurodevelopmental disorders. Acta Crystallographica Section A Foundations and Advances, 81(a1), e266-e266. https://doi.org/10.1107/s2053273325097359
Vancouver
Havlickova P, Koutska A, Smatanova IK, Fenckova M. When signaling goes astray: understanding MAP2K1 mutations in neurodevelopmental disorders. Acta Crystallographica Section A Foundations and Advances. 2026;81(a1):e266-e266. doi:10.1107/s2053273325097359
BibTeX
@article{Havlickova2026,
author = {Havlickova, P. and Koutska, A. and Smatanova, I. Kuta and Fenckova, M.},
title = {When signaling goes astray: understanding MAP2K1 mutations in neurodevelopmental disorders},
journal = {Acta Crystallographica Section A Foundations and Advances},
year = {2026},
volume = {81},
number = {a1},
pages = {e266--e266},
doi = {10.1107/s2053273325097359}
}
EUVIMED